IP Library › Granted Patent US 7,960,399
Granted Patent B2
US 7,960,399 · App. 11/569,802 · Granted Jun 14, 2011

Quinazolinone derivatives useful as vanilloid antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,399
App. No.
11/569,802
Granted
Jun 14, 2011
Kind
B2
Abstract

The present invention relates to the use of a quinazolinone compound of the formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid.

Claims (5)

1. A compound of the formula:

in free form or in pharmaceutically acceptable salt form.

2. The compound of claim 1 , wherein the compound is in pharmaceutically acceptable salt form.

3. A pharmaceutical composition comprising a compound of claim 1 , in free form or pharmaceutically acceptable salt form, in association with a pharmaceutical carrier or diluent.

4. The compound of claim 1 , wherein the compound is in free form.

Assignments (4)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 074050/0573 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0682 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0709 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: NOVARTIS AG
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065790/0208 →